Exagen reports preliminary 2025 revenue of $66M to $67M
Go back to Exagen reports preliminary 2025 revenue of $66M to $67M| (NASDAQ: XGN) | Delayed: 7.25 -0.09 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.34 | 52 Week High | $0.46 | |||
| Open | $7.25 | 52 Week Low | $0.46 | |||
| Day High | $7.44 | P/E | N/A | |||
| Day Low | $7.16 | EPS | $0.00 | |||
| Volume | 87,313 | |||||

